The only problem with that I see is that what Merck did in 6 months will most likely take IPIX a year or more due to finances. Sure hope the follow up results due out by end of month show something positive and that the Compassionate Use data (where dosage and dosings were different) provides some further positive data. If so, then Leo should jump on a BP partner big time as quickly as possible for B-Covid.

Very disturbing today, but definitely not down for the count IMO.